AcelRx Stock Jumps 20% After Positive Results From Its Trial On ARX-04
September 15, 2016 at 07:32 AM EDT
AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) disclosed that its investigational product candidate ARX-04 provided solid tolerance level ...